Incidence, presentation and outcome of toxoplasmosis in HIV infected in the combination antiretroviral therapy era.

•Data from the Danish HIV Cohort Study – a nationwide population-based cohort study.•Declining incidence of CTX in the cART-era after surviving the 1st year.•Declining CTX mortality in the cART-era, specially after surviving the first 3 months.•CTX remains an important cause of morbidity and mortality in late presenters.•CTX has an important impact in the patient's later well being and quality of life.